Happy holidays from FierceBiotech IT!

Rather than dazzle you with a clever, rhyming list of gifts for the biotech biggies, we're going to let you off easy with a simple George Miller, Fiercepharmamanufacuring Editoracknowledgment:

Here's to you and the work you do! Your daily efforts are part of a great technology project to save lives and improve the quality of existence for a growing proportion of the earth's 6.8 billion residents. Through your efforts, prophylactics and treatments are reaching farther and wider than ever before and making a planet-sized impact. Congratulations on a job well done!

And take some time off next week, as are we at FierceMarkets. We'll see you again on January 4, 2010. - George

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.